DiscoverMedscape InDiscussion: Psoriasis
Medscape InDiscussion: Psoriasis
Claim Ownership

Medscape InDiscussion: Psoriasis

Author: Medscape

Subscribed: 13Played: 65
Share

Description

Listen to Medscape InDiscussion: Psoriasis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/ca8/p04/podcast-psoriasis-s1-ep1-2026a1000511). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
24 Episodes
Reverse
Many patients ask whether changing what they eat can help their psoriasis. Dr Joel Gelfand reviews the MEDIPSO trial and explains when a Mediterranean diet may meaningfully improve disease severity. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep6-2026a10006hq. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Psoriasis https://emedicine.medscape.com/article/1943419-overview Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/40991259/ Evaluating Psoriasis With Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment https://pubmed.ncbi.nlm.nih.gov/15389191/ International Psoriasis Council https://psoriasiscouncil.org/ Mediterranean Diet and Cardiovascular Health: Teachings of the PREDIMED Study https://pubmed.ncbi.nlm.nih.gov/24829485/ Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39319513/ PCORI — Patient-Centered Outcomes Research Institute https://www.pcori.org/ Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The Correlation Between Disease Severity and Psychological Burden in Patients Treated With Biological Therapies https://pubmed.ncbi.nlm.nih.gov/23425140/ Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial https://pubmed.ncbi.nlm.nih.gov/29776990/ The Health Benefits of UV Radiation Exposure Through Vitamin D Production or Non-Vitamin D Pathways. Blood Pressure and Cardiovascular Disease https://pubmed.ncbi.nlm.nih.gov/28009890/ Using Guidelines of Care to Lower Cardiovascular Risk in Patients With Psoriasis https://pubmed.ncbi.nlm.nih.gov/38796273/ Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis (CP3) Study: Preliminary Results https://www.med.upenn.edu/gelfand/assets/user-content/documents/cp3-isidposter2023-an.pdf Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Dr Faranak Kamangar joins Dr Steven Feldman to discuss how AI tools are cutting psoriasis admin hours, improving diagnostic accuracy, and freeing clinicians for more patient-facing care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep5-2026a10006hn. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.   Resources Psoriasis https://emedicine.medscape.com/article/1943419-overview DermGPT https://www.dermgpt.com/ PSO Telehealth https://www.psotelehealth.com/ The Future of Dermatology https://thefutureofdermatology.podbean.com/ Evaluating Psoriasis With Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician’s Global Assessment https://pubmed.ncbi.nlm.nih.gov/15389191/ Functional Genomics in Psoriasis https://pubmed.ncbi.nlm.nih.gov/39000456/ Psoriatic Arthritis https://emedicine.medscape.com/article/2196539-overview Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era? https://pubmed.ncbi.nlm.nih.gov/39259262/ Automated Triage of Cancer-Suspicious Skin Lesions With 3D Total-Body Photography https://pubmed.ncbi.nlm.nih.gov/41272121/ Current Therapeutic Overview and Future Perspectives Regarding the Treatment of Psoriasis https://pubmed.ncbi.nlm.nih.gov/39405929/ Comparing Physician and Artificial Intelligence Chatbot Responses to Patient Questions Posted to a Public Social Media Forum https://pubmed.ncbi.nlm.nih.gov/37115527/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep4-2026a10006hl. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.   Resources Psoriasis https://emedicine.medscape.com/article/1943419-overview Lyme Disease https://emedicine.medscape.com/article/330178-overview Synovial Fluid Eosinophilia in Lyme Disease https://pubmed.ncbi.nlm.nih.gov/3056421/ Rheumatoid Arthritis (RA) Treatment & Management https://emedicine.medscape.com/article/331715-treatment Psoriatic Arthritis Treatment & Management https://emedicine.medscape.com/article/2196539-treatment#d9 A Review of Biosimilars for Rheumatoid Arthritis https://pubmed.ncbi.nlm.nih.gov/35552095/ Drift, Evolution, and Divergence in Biologics and Biosimilars https://pubmed.ncbi.nlm.nih.gov/24567263/ FDA Updates Guidance on Interchangeability https://www.fda.gov/drugs/drug-alerts-and-statements/fda-updates-guidance-interchangeability Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention https://pubmed.ncbi.nlm.nih.gov/32205569/ Physicochemical and Biological Similarity Assessment of LBAL, a Biosimilar to Adalimumab Reference Product (Humira®) https://pubmed.ncbi.nlm.nih.gov/34262661/ GP2017, an Adalimumab Biosimilar: Pharmacokinetic Similarity to Its Reference Medicine and Pharmacokinetics Comparison of Different Administration Methods https://pubmed.ncbi.nlm.nih.gov/30698045/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep3-2026a10006hk. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Psoriasis https://emedicine.medscape.com/article/1943419-overview Psoriasis: An Update on Topical and Systemic Therapies https://pubmed.ncbi.nlm.nih.gov/40568686/ Crosstalk Between White Adipose Tissue and Skin: Unraveling Its Role in Psoriasis Pathogenesis (Review) https://pubmed.ncbi.nlm.nih.gov/40242953/ Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis With Biologics https://pubmed.ncbi.nlm.nih.gov/30772098/ Joint American Academy of Dermatology-National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologic Therapies https://pubmed.ncbi.nlm.nih.gov/32119894/ Oral Janus Kinase Inhibitors in the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis https://pubmed.ncbi.nlm.nih.gov/36751339/ Janus Kinase Inhibitors for Alopecia Areata: A Review of Clinical Data https://pubmed.ncbi.nlm.nih.gov/40433365/ Herpes Zoster https://emedicine.medscape.com/article/1132465-overview Clinical Testing Guidance for Tuberculosis: Interferon Gamma Release Assay https://www.cdc.gov/tb/hcp/testing-diagnosis/interferon-gamma-release-assay.html Utility of Repeat Latent Tuberculosis Testing With the QuantiFERON-TB Gold Test in Patients With Psoriasis Treated With Tumour Necrosis Factor-α Inhibitors at a Single U.S. Institution https://pubmed.ncbi.nlm.nih.gov/31452192/ Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Drs Steven Feldman and Tina Bhutani-Jacques explore how next-generation oral therapies are closing the gap with biologics and reshaping psoriasis care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Acitretin Revisited in the Era of Biologics https://pubmed.ncbi.nlm.nih.gov/20673152/ Apremilast in Psoriasis: Current Landscape and Perspectives https://pubmed.ncbi.nlm.nih.gov/40739686/ Deucravacitinib Versus Placebo and Apremilast in Moderate-to-Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial https://pubmed.ncbi.nlm.nih.gov/35820547/ Apremilast Prescribing Information https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf Deucravacitinib Prescribing Information https://packageinserts.bms.com/pi/pi_sotyktu.pdf Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39167366/ Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/ Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/ National Psoriasis Foundation https://www.psoriasis.org/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
loading
Comments